Form4insider filings, from the source

SEC Form 4 · accession 0001628280-26-063221

CASTLE BIOSCIENCES INC · CSTL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Derek J Maetzold
Officer — Pres. & Chief Exec. Officer · Director
Period of report
Sep 21, 2026
Accepted (ET)
Sep 23, 2026 · 4:27 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001447362

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockSep 21, 2026M8,580$2.39A30,059D
Common StockF2Sep 21, 2026S8,580$35.334D21,479D
Common StockF2,F3Sep 21, 2026S3,198$35.334D11,236IBy The Maetzold Descendants 2020 Trust
Common StockF2,F4Sep 21, 2026S2,718$35.334D9,550IBy Derek Maetzold 2020 Irrevocable Trust
Common StockF5holding———11,256IBy The Maetzold 2018 Remainder Trust FBO Emily Carol Kirk
Common StockF6holding———11,256IBy The Maetzold 2018 Remainder Trust FBO Hannah Elizabeth Maetzold
Common StockF7holding———11,256IBy The Maetzold 2018 Remainder Trust FBO John Derek Maetzold
Common StockF8holding———11,256IBy The Maetzold 2018 Remainder Trust FBO Peter Douglas Maetzold
Common StockF9holding———11,963IBy DJM Grantor Retained Annuity Trust No. 6
Common StockF10holding———27,862IBy DJM Grantor Retained Annuity Trust No. 7
Common StockF11holding———40,935IBy DJM Grantor Retained Annuity Trust No. 8
Common StockF12holding———23,216IDJM Grantor Retained Annuity Trust No. 9

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock option (right to buy)F13$2.39Sep 21, 2026M8,580D—May 9, 2028Common Stock8,5808,165D

Explanation of responses